Trapidil is an antiplatelet medicine used to prevent blood clots from forming. It belongs to a class of drugs called platelet aggregation inhibitors. It works by blocking certain chemical signals in the body that promote clotting. Trapidil is usually taken as a single daily dose and is used to prevent heart attack, stroke, and other serious cardiovascular events in people with a history of these conditions. It can also be used to prevent recurrent blood clots in the legs or lungs.
Trapidil is a medication with a somewhat interesting history. While it's not widely used today, it has some interesting properties:
Original Purpose:
- Developed as a vasodilator and antiplatelet agent [1, 2].
- Vasodilator: Relaxes blood vessels, potentially increasing blood flow and lowering blood pressure.
- Antiplatelet agent: Reduces the ability of platelets (blood clotting cells) to clump together, which could help prevent blood clots.
Potential Uses (investigational):
- There was some research on Trapidil for treating ischemic conditions like coronary heart disease, liver disease, and kidney disease due to its blood flow effects [2, 5].
- More recent studies have explored Trapidil's potential effects on bone health and reducing restenosis (renarrowing) after coronary angioplasty (a procedure to open blocked arteries) [4, 5].
Important Notes:
- Trapidil is not a common medication anymore and may not be widely available.
- There is limited current information on its effectiveness for most conditions it was investigated for.
- More research is needed to confirm its potential benefits and safety for these uses.
Current Use:
- There is no single, widely accepted use for Trapidil in modern medicine.
Anatomical Therapeutic Chemical Classification
C - Cardiovascular system
C01 Cardiac therapy
C01D - Vasodilators used in cardiac diseases
C01DX Other vasodilators used in cardiac diseases
ATC Code
External Links